Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc. (NASDAQ: COCO) files reports and disclosures with the U.S. Securities and Exchange Commission as part of its obligations as a public company. This page compiles those SEC filings and pairs them with AI-powered tools that help explain the information contained in key documents.
Through its filings, the company reports on topics such as quarterly and annual financial performance, business developments, and regulatory matters. Recent Form 8-K filings, for example, reference press releases announcing financial results for quarters ended June 30 and September 30, 2025, as well as a company statement regarding tariff relief affecting coconut water products. These filings provide detail on net sales, gross profit, net income, and non-GAAP measures like Adjusted EBITDA, along with management’s commentary on factors such as tariffs, costs, and demand for Vita Coco Coconut Water and related products.
On this page, users can access core documents such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K as they become available through EDGAR. AI-generated summaries are designed to highlight major themes, clarify technical language, and surface items that may matter to shareholders, such as segment performance, tariff discussions, or capital allocation programs mentioned in earnings releases.
In addition, this page provides convenient access to insider transaction reports on Form 4 and other ownership-related filings when they are filed. Together, these resources allow investors, analysts, and interested readers to review The Vita Coco Company’s regulatory disclosures in one place, with AI assistance to make complex filings easier to understand.
Vita Coco Company, Inc. CEO Martin Roper exercised stock options and sold the resulting shares. He exercised options for 29,456 shares of common stock at an exercise price of $10.178 per share, then sold 29,456 shares in open-market trades at weighted average prices around $50-$51.10 under a Rule 10b5-1 trading plan. After these transactions, he directly holds 298,484 common shares, alongside additional indirect holdings through family trusts and his spouse.
Martin Roper submitted a Form 144 notice proposing the sale of 25,000 shares of Common Stock (aggregate $1,250,000.00) through Fidelity Brokerage Services LLC on 04/14/2026. The filing also lists recent sales executed 04/07/2026 (25,000 for $1,250,000.00), 04/08/2026 (25,000 for $1,273,740.00), 04/10/2026 (25,000 for $1,252,680.00), and 04/13/2026 (4,456 for $225,248.13).
COCO reported officer/affiliate sales under Rule 144. Martin Roper furnished notices for three open-market dispositions of Common stock: 25,000 shares on 04/07/2026 for $1,250,000, 25,000 shares on 04/08/2026 for $1,273,740, and 25,000 shares on 04/10/2026 for $1,252,680. The filing lists Fidelity Brokerage Services LLC as a broker and references an option granted on 09/19/2019.
The Vita Coco Company, Inc. announced that board member John Leahy will retire from its Board of Directors and will not stand for reelection at the Company’s 2026 Annual Meeting of Stockholders on June 3, 2026. He has served on the Board since 2019 and is a member of both the Audit Committee and the Compensation Committee, continuing in these roles until his term ends at the meeting. The Company states that Mr. Leahy’s decision is solely for personal reasons and not due to any disagreement over operations, policies, or practices. After his retirement, the Board’s size will decrease from ten members to nine.
COCO reported proposed and recent Section 144 sales of common stock. The filing lists a proposed sale of 25,000 shares on 04/10/2026 tied to an Option Granted - 09/19/2019 with cash settlement. It also records two recent sales by Martin Roper: 25,000 shares on 04/07/2026 for $1,250,000 and 25,000 shares on 04/08/2026 for $1,273,740.
Vita Coco Company, Inc. chief executive Martin Roper exercised stock options and sold shares in coordinated transactions. On April 7 and 8, he exercised options to acquire a total of 50,000 shares of common stock at an exercise price of $10.178 per share, then sold 50,000 shares in open-market trades at weighted average prices of approximately $50.00 and $50.949 per share. After these transactions, he directly holds 298,484 common shares and retains multiple blocks of non-qualified stock options with exercise prices ranging from $10.178 to $32.780 per share. The sales were made under a pre-arranged Rule 10b5-1 trading plan.
Martin Roper reported a proposed sale of 25,000 shares of Common Stock of COCO. The filing shows a sale dated 04/07/2026 with proceeds of $1,250,000.00 and a related broker entry for 25,000 shares through Fidelity Brokerage Services LLC on 04/08/2026. An option grant date of 09/19/2019 is noted.
BlackRock, Inc. amended a Schedule 13G/A to report beneficial ownership of 6,634,636 shares of The Vita Coco Company Inc (Common Stock), representing 11.6% of the class as stated in the filing. The amendment attributes ownership to certain Reporting Business Units of BlackRock and shows 6,555,826 shares of sole voting power and 6,634,636 shares of sole dispositive power. The filing lists BlackRock's address and includes Exhibits 24 and 99 and is signed by a Managing Director on 04/07/2026.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of common stock on April 1, 2026 at $48.67 per share. The sale was effected under a Rule 10b5-1 trading plan.
Following this sale, he directly owns 77,691 shares of common stock. He also holds multiple non-qualified stock options to buy Vita Coco common stock, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates between 2030 and 2035.